Boehringer Ingelheim Jobs in St. Joseph, MO.
Boehringer Ingelheim Vetmedica, Inc.
Boehringer Ingelheim Vetmedica, Inc., a subsidiary of Boehringer Ingelheim Corporation since 1981, is headquartered in St. Joseph, MO. From four sites, St. Joseph, MO; Elwood, KS; Sioux Center, IA; and Ames, IA, this USA subsidiary acts as a center of competence in biological research, development, and manufacturing for the worldwide animal health business. The St. Joseph, MO campus recently added a state of the art biological manufacturing facility, a research and development complex, and new centralized warehousing facilities.
Innovative, dedicated, market-oriented Boehringer Ingelheim people accept the challenge of delivering high quality, innovative animal health products to you. Today and tomorrow, locally, nationally, internationally.
Use Boehringer Ingelheim Vetmedica, Inc., animal health products with confidence. In the cattle industry look for these beef friendly and dairy friendly brand name vaccines, ALPHA™ (Alpha-7, Alpha-CD, ALPHA-7/MB-1 ), EXPRESS™ (Express 5-PHM, Express 5, Express 5-HS, Express 10, Express 10-HS) CALIBER™ (Caliber 7, Caliber 3), PULMO-GUARD™ (Pulmo-guard PH-M, Pulmo-guard PHM-1, Pulmo-guard PH-M/SDT) In swine production, look for these innovative Boehringer Ingelheim Vetmedica, Inc. vaccines-- INGELVAC® PRRS ATP, PRRS MLV, M HYO, and ENTERISOL® ILEITIS. Horse owners and veterinarians, through Boehringer Ingelheim research and development, have pharmaceuticals like VENTIPULMIN® SYRUP available to keep horses breathing easier. Still other brand names include BIO-MYCIN® 200 oxytetracycline injection antibiotic. Soon, pet owners will come to know brand names that allow their pets to lead longer, healthier, happier lives.
The Boehringer Ingelheim group of companies, with headquarters in Ingelheim, Germany is one of the 20 leading pharmaceutical firms in the world. Boehringer Ingelheim, with some 140 affiliated companies worldwide, focuses on human pharmaceuticals and animal health.
Our employees are our greatest asset...
The commitment, competence and creative power of our people, sustained for well over a century, have made Boehringer Ingelheim a first-class, fast-growing pharmaceutical corporation. This is reflected in the energy and innovation of more than 39,800 employees. We offer our employees demanding and challenging tasks and the appropriate chances for development and career advancement at national and international level, as well as performance-related and results-driven remuneration.
Who we are...
The Boehringer Ingelheim group is one of the world's 20 leading pharmaceutical companies. Family owned and headquartered in Ingelheim, Germany, it operates globally with 135 affiliates in 47 countries and 39,800 employees. Here are some interesting employee statistics.
In 2007:
- the total number of people working for us worldwide rose by 3.6%.
- our workforce in Europe rose 3.9 % to 20,682.
- our employees in the Americas increased by 450 (+3.5%).
- 15,095 of our people worked in Marketing & Sales (+5.1%).
- 12,502 worked in production worldwide (+1.0%).
- our employees working in Research & Development reached 6,405.
- 45.1% of our employees were female.
- Boehringer Ingelheim employed 703 apprentices (660 in Germany).
What we do...
Since it was founded in 1885, the family-owned company has been committed to researching, developing, manufacturing and marketing novel products of high therapeutic value for human and veterinary medicine. In 2007, Boehringer Ingelheim posted net sales of 10.9 billion euro while investing one fifth of net sales in its largest business segment Prescription Medicines on research and development.
